Duks Pharma Private Limited

Duks Pharma Private Limited - trading in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51909UP2020PTC132389 Incorporated 08 August 2020 ROC Kanpur HQ Meerut, Uttar Pradesh, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2024
₹39.26 Lakh
▼ 4% YoY
Net profit · FY 2024
₹8,480
Net margin 0.2%
EBITDA · FY 2024
₹1.14 Lakh
EBITDA margin 2.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Duks Pharma Private Limited

Data last updated:

Duks Pharma Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 08 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2020PTC132389. Its GSTIN is 09AAHCD8943P1ZR (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Pankaj Sharma and Premlata.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 44 Shri Ram Ji Vatika Colony Mawana Road Incholi, Meerut, Uttar Pradesh, India – 250001.

As per the financials filed for FY 2024, the company reported a revenue of ₹39.26 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹8,480 (net margin 0.2%) and EBITDA of ₹1.14 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 250% over three years.

Company Details of Duks Pharma Private Limited
CIN U51909UP2020PTC132389
Registration Number 132389
Incorporation Date 08 August 2020
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    44 Shri Ram Ji Vatika Colony Mawana Road Incholi, Meerut, Uttar Pradesh, India – 250001
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Duks Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Duks Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Duks Pharma Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Duks Pharma Private Limited

The main business activity of Duks Pharma is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Duks Pharma Private Limited FY 2025 filings available

Duks Pharma Private Limited reported revenue of ₹39.26 Lakh (down 4% YoY) for FY 2024.

Revenue · FY 2024
₹39.26 Lakh ▼ 4%
Net profit · FY 2024
₹8,480 margin 0.2%
EBITDA · FY 2024
₹1.14 Lakh margin 2.9%

Compounded Annual Growth Rate (CAGR) of Duks Pharma Private Limited

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 250%
EBITDA CAGR growth
1 year
▲ 937%
3 years · compounded
▲ 88%

Revenue fell 4% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 250%. EBITDA rose 937% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Duks Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹1.14 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹8,480••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Duks Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.9%••••••••••••
Net Profit Margin0.2%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Duks Pharma are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Duks Pharma Private Limited

Duks Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
PNG Enterprises Private Limited₹39.3 Lakh (FY 2025)••••••••225.0%••••Ghaziabad, Uttar Pradesh, India
Oxylink Healthcare Private Limited₹39.3 Lakh (FY 2024)••••••••-60.0%••••Delhi, India
Anupama Devcon Private Limited₹39.3 Lakh (FY 2024)••••••••-90.0%••••Chapra, Bihar, India
Puriya Projects Private Limited₹39.29 Lakh (FY 2023)••••••••2.0%••••Hajipur, Bihar, India
Kuchh Khurak (India) Private Limited₹39.27 Lakh (FY 2023)••••••••-59.0%••••Vaishali, Bihar, India
Duks Pharma Private Limited this company₹39.26 Lakh (FY 2024)••••••••-4.0%••••Meerut, Uttar Pradesh, India
Farmjoy Crop Research Private Limited₹39.26 Lakh (FY 2025)••••••••-1.0%••••New Delhi, Delhi, India
Nexxa Solar Power Technologies Private Limited₹39.26 Lakh (FY 2020)••••••••••••Nashik Road, Nashik, Maharashtra, India
Vishwakarta Farmer Producer Company Limited₹39.25 Lakh (FY 2024)••••••••670.0%••••Parbhani, Maharashtra, India
Aariv Exim Private Limited₹39.24 Lakh (FY 2025)••••••••-21.0%••••Shahibaug, Ahmedabad, Gujarat, India
Muenot Technologies (OPC) Private Limited₹39.24 Lakh (FY 2025)••••••••336.0%••••Jhunjhunu, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Duks Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Duks Pharma Private Limited

Duks Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pankaj SharmaDirector08 Aug 20206 Years 2 MonthsCurrent
PremlataDirector08 Aug 20206 Years 2 MonthsCurrent

Ownership and Shareholding of Duks Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Duks Pharma Private Limited

Duks Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Duks Pharma Private Limited

Duks Pharma Private Limited has a workforce of 0 employees as of Apr 09, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Duks Pharma Private Limited

Duks Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Pankaj Sharma was appointed as Director on 08 Aug 2020.

AGM
Duks Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Duks Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Pankaj Sharma was appointed as Director.
Appointed
Premlata was appointed as Director.
Incorporation
08 Aug 2020
Duks Pharma Private Limited was registered on 08 Aug 2020 with Roc Kanpur & aged 6 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Duks Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Duks Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Duks Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Duks Pharma Private Limited

Duks Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAHCD8943P1ZRUttar PradeshActive11 Feb 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Duks Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Duks Pharma Private Limited

Duks Pharma is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 08 August 2020 (6+ years old) and is registered under CIN U51909UP2020PTC132389.

Duks Pharma reported revenue of ₹39.26 Lakh for FY 2024 (down 4% YoY).

Duks Pharma has 2 current directors:

Duks Pharma reported a net profit of ₹8,480 (net margin 0.2%) and EBITDA of ₹1.14 Lakh (EBITDA margin 2.9%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Duks Pharma is 250% over three years. In the latest year (FY 2024) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Duks Pharma is 09AAHCD8943P1ZR, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Duks Pharma is U51909UP2020PTC132389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Duks Pharma was incorporated on 08 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Duks Pharma by revenue are PNG Enterprises Private Limited, Oxylink Healthcare Private Limited, Anupama Devcon Private Limited, Puriya Projects Private Limited, Kuchh Khurak (India) Private Limited and 5 more, all in the same principal business activity (Retail Trading).

Pankaj Sharma was appointed as Director on 08 Aug 2020. Premlata was appointed as Director on 08 Aug 2020.

The registered office of Duks Pharma is at 44 Shri Ram Ji Vatika Colony Mawana Road Incholi, Meerut, Uttar Pradesh, India – 250001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available